

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.90719573 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.79398679 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.78277967 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.69431251 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.34568522 |
| 6 | protein localization to synapse (GO:0035418) | 5.29154523 |
| 7 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.25904650 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.25878048 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.23884301 |
| 10 | synaptic vesicle maturation (GO:0016188) | 5.23796523 |
| 11 | dendritic spine morphogenesis (GO:0060997) | 4.86942563 |
| 12 | * neuron cell-cell adhesion (GO:0007158) | 4.79083467 |
| 13 | glutamate secretion (GO:0014047) | 4.74830277 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.71128929 |
| 15 | * ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.70134268 |
| 16 | exploration behavior (GO:0035640) | 4.64093363 |
| 17 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.59766862 |
| 18 | * neuron recognition (GO:0008038) | 4.42021968 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.38105163 |
| 20 | * glutamate receptor signaling pathway (GO:0007215) | 4.37912433 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 4.34001224 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.33364924 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 4.27675493 |
| 24 | establishment of mitochondrion localization (GO:0051654) | 4.26173913 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.26030189 |
| 26 | neuronal action potential propagation (GO:0019227) | 4.24715875 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 4.20719547 |
| 28 | neurotransmitter secretion (GO:0007269) | 4.20141257 |
| 29 | * layer formation in cerebral cortex (GO:0021819) | 4.12032079 |
| 30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.11784401 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 4.08811361 |
| 32 | nucleobase catabolic process (GO:0046113) | 4.07654500 |
| 33 | cerebellar granule cell differentiation (GO:0021707) | 4.07621531 |
| 34 | sodium ion export (GO:0071436) | 3.99045433 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.97372238 |
| 36 | postsynaptic membrane organization (GO:0001941) | 3.95227465 |
| 37 | positive regulation of synapse maturation (GO:0090129) | 3.93173201 |
| 38 | gamma-aminobutyric acid transport (GO:0015812) | 3.86296239 |
| 39 | positive regulation of membrane potential (GO:0045838) | 3.81363210 |
| 40 | long-term memory (GO:0007616) | 3.80897361 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.80681195 |
| 42 | proline transport (GO:0015824) | 3.78172099 |
| 43 | presynaptic membrane assembly (GO:0097105) | 3.72710057 |
| 44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.70697024 |
| 45 | cell migration in hindbrain (GO:0021535) | 3.67976184 |
| 46 | transmission of nerve impulse (GO:0019226) | 3.65856568 |
| 47 | * axonal fasciculation (GO:0007413) | 3.65452258 |
| 48 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.65262703 |
| 49 | dendrite morphogenesis (GO:0048813) | 3.64903431 |
| 50 | L-amino acid import (GO:0043092) | 3.64454815 |
| 51 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.60950938 |
| 52 | * regulation of dendritic spine morphogenesis (GO:0061001) | 3.60609089 |
| 53 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.54910553 |
| 54 | mitochondrion transport along microtubule (GO:0047497) | 3.54910553 |
| 55 | membrane depolarization during action potential (GO:0086010) | 3.53571020 |
| 56 | regulation of synaptic plasticity (GO:0048167) | 3.53558011 |
| 57 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.51340074 |
| 58 | presynaptic membrane organization (GO:0097090) | 3.49710454 |
| 59 | auditory behavior (GO:0031223) | 3.49589648 |
| 60 | positive regulation of dendritic spine development (GO:0060999) | 3.45636287 |
| 61 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.43318348 |
| 62 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.42684706 |
| 63 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.42547652 |
| 64 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.42083288 |
| 65 | neurotransmitter transport (GO:0006836) | 3.41525099 |
| 66 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.41296174 |
| 67 | synaptic vesicle endocytosis (GO:0048488) | 3.40507929 |
| 68 | dendritic spine organization (GO:0097061) | 3.40121425 |
| 69 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.38069262 |
| 70 | regulation of vesicle fusion (GO:0031338) | 3.37058634 |
| 71 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.35670518 |
| 72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.34809781 |
| 73 | prepulse inhibition (GO:0060134) | 3.33187921 |
| 74 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.32253003 |
| 75 | neuromuscular process controlling balance (GO:0050885) | 3.31443224 |
| 76 | synapse assembly (GO:0007416) | 3.29257259 |
| 77 | regulation of neurotransmitter secretion (GO:0046928) | 3.28036623 |
| 78 | long-term synaptic potentiation (GO:0060291) | 3.27975966 |
| 79 | startle response (GO:0001964) | 3.26488579 |
| 80 | behavioral fear response (GO:0001662) | 3.26231397 |
| 81 | behavioral defense response (GO:0002209) | 3.26231397 |
| 82 | activation of protein kinase A activity (GO:0034199) | 3.25302572 |
| 83 | neuromuscular synaptic transmission (GO:0007274) | 3.24406400 |
| 84 | * regulation of dendritic spine development (GO:0060998) | 3.23824553 |
| 85 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.23486104 |
| 86 | response to histamine (GO:0034776) | 3.23277698 |
| 87 | response to auditory stimulus (GO:0010996) | 3.22071978 |
| 88 | learning (GO:0007612) | 3.21396806 |
| 89 | amino acid import (GO:0043090) | 3.20050099 |
| 90 | membrane depolarization (GO:0051899) | 3.19478823 |
| 91 | positive regulation of neurotransmitter transport (GO:0051590) | 3.18001708 |
| 92 | intraspecies interaction between organisms (GO:0051703) | 3.17879558 |
| 93 | social behavior (GO:0035176) | 3.17879558 |
| 94 | regulation of neurotransmitter levels (GO:0001505) | 3.17586031 |
| 95 | adult walking behavior (GO:0007628) | 3.15188246 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.14314060 |
| 97 | positive regulation of synapse assembly (GO:0051965) | 3.14060133 |
| 98 | mechanosensory behavior (GO:0007638) | 3.11795228 |
| 99 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.11230398 |
| 100 | negative regulation of dendrite development (GO:2000171) | 3.10538711 |
| 101 | regulation of synapse maturation (GO:0090128) | 3.10096067 |
| 102 | fear response (GO:0042596) | 3.08828288 |
| 103 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.08533071 |
| 104 | cellular potassium ion homeostasis (GO:0030007) | 3.07110086 |
| 105 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.06812543 |
| 106 | synaptic transmission (GO:0007268) | 3.05070447 |
| 107 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04081097 |
| 108 | neuronal ion channel clustering (GO:0045161) | 3.04016865 |
| 109 | membrane hyperpolarization (GO:0060081) | 3.02719994 |
| 110 | neuromuscular process (GO:0050905) | 3.01419563 |
| 111 | innervation (GO:0060384) | 3.01380606 |
| 112 | synapse organization (GO:0050808) | 3.01172465 |
| 113 | regulation of neurotransmitter transport (GO:0051588) | 3.00208795 |
| 114 | potassium ion import (GO:0010107) | 3.00201258 |
| 115 | potassium ion homeostasis (GO:0055075) | 2.99832065 |
| 116 | neurofilament cytoskeleton organization (GO:0060052) | 2.99065371 |
| 117 | behavioral response to cocaine (GO:0048148) | 2.97737797 |
| 118 | mating behavior (GO:0007617) | 2.97324783 |
| 119 | dopamine receptor signaling pathway (GO:0007212) | 2.95628803 |
| 120 | regulation of glutamate secretion (GO:0014048) | 2.94753221 |
| 121 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.94154647 |
| 122 | regulation of synaptic transmission (GO:0050804) | 2.92786505 |
| 123 | negative regulation of microtubule polymerization (GO:0031115) | 2.92499754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.64756146 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.60361736 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.26063716 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.17715695 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04663320 |
| 6 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.76780653 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76287465 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76287465 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74118546 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.72213473 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.66840894 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55633144 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52585709 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47650519 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46911042 |
| 16 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.46102463 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35943033 |
| 18 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.34538512 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32387141 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.31748823 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.29804022 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.29184501 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14588798 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.06183945 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96151018 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95329590 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.94397682 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.93276425 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.92656409 |
| 30 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91758862 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.81941780 |
| 32 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.81286645 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77424982 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71578125 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62468357 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59792061 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56834821 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56696939 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56375402 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54824922 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50986356 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48759463 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43506851 |
| 44 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42163006 |
| 45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38590760 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37424526 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35253922 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34409640 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29339761 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29280965 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29089827 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26691592 |
| 53 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.25661790 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23826420 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23727262 |
| 56 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.21497027 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21350991 |
| 58 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20338344 |
| 59 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19967325 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17034606 |
| 61 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.15814861 |
| 62 | AR_19668381_ChIP-Seq_PC3_Human | 1.15278959 |
| 63 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14778637 |
| 64 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14684408 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14082860 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13568125 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12648470 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12451438 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11598278 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11430176 |
| 71 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.11264775 |
| 72 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09324646 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07254158 |
| 74 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06780161 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05160501 |
| 76 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04497946 |
| 77 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04200851 |
| 78 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04065519 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02807450 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02788181 |
| 81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01930389 |
| 82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01636223 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00984873 |
| 84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00761421 |
| 85 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00613019 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99981361 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99125416 |
| 88 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98732470 |
| 89 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98732470 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97930989 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97781745 |
| 92 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97414475 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97035710 |
| 94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96620517 |
| 95 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94983223 |
| 96 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94466204 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94204104 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94200266 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94175196 |
| 100 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.93809429 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93678763 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93196276 |
| 103 | JUN_21703547_ChIP-Seq_K562_Human | 0.92903370 |
| 104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92267158 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91726847 |
| 106 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.91707940 |
| 107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91130888 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91058531 |
| 109 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90489422 |
| 110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89336179 |
| 111 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88847789 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88815784 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88514121 |
| 114 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88096190 |
| 115 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.84866795 |
| 116 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.82564470 |
| 117 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80931584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.37693017 |
| 2 | MP0003880_abnormal_central_pattern | 5.67625761 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.18774202 |
| 4 | * MP0002063_abnormal_learning/memory/cond | 3.46552998 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.37354761 |
| 6 | * MP0004270_analgesia | 3.20696399 |
| 7 | MP0005423_abnormal_somatic_nervous | 3.16598625 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.02162210 |
| 9 | * MP0002064_seizures | 3.00254838 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.87257272 |
| 11 | MP0009046_muscle_twitch | 2.82542404 |
| 12 | MP0001486_abnormal_startle_reflex | 2.63681579 |
| 13 | * MP0002734_abnormal_mechanical_nocicepti | 2.50422394 |
| 14 | MP0002822_catalepsy | 2.48679910 |
| 15 | MP0002272_abnormal_nervous_system | 2.44646924 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.30578689 |
| 17 | * MP0000778_abnormal_nervous_system | 2.30456079 |
| 18 | MP0002736_abnormal_nociception_after | 2.29759682 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.24281301 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.21888809 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.15637804 |
| 22 | MP0002184_abnormal_innervation | 2.06734264 |
| 23 | * MP0002733_abnormal_thermal_nociception | 1.98667172 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.95737491 |
| 25 | * MP0001970_abnormal_pain_threshold | 1.89418141 |
| 26 | MP0002557_abnormal_social/conspecific_i | 1.88946681 |
| 27 | MP0003329_amyloid_beta_deposits | 1.87532414 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.87302360 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.82710456 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.79911523 |
| 31 | MP0004924_abnormal_behavior | 1.79911523 |
| 32 | MP0001529_abnormal_vocalization | 1.66816481 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.64746005 |
| 34 | MP0008569_lethality_at_weaning | 1.62285551 |
| 35 | * MP0000955_abnormal_spinal_cord | 1.59360258 |
| 36 | MP0004858_abnormal_nervous_system | 1.58982529 |
| 37 | MP0001984_abnormal_olfaction | 1.57133845 |
| 38 | MP0001188_hyperpigmentation | 1.46959865 |
| 39 | * MP0002882_abnormal_neuron_morphology | 1.46893092 |
| 40 | MP0003879_abnormal_hair_cell | 1.42512953 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.42357061 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.41912660 |
| 43 | MP0004885_abnormal_endolymph | 1.39583635 |
| 44 | MP0003787_abnormal_imprinting | 1.35601190 |
| 45 | MP0001905_abnormal_dopamine_level | 1.33755996 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.33150193 |
| 47 | MP0003121_genomic_imprinting | 1.25906481 |
| 48 | * MP0002152_abnormal_brain_morphology | 1.24097308 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.24086560 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.20929870 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.18505237 |
| 52 | MP0004142_abnormal_muscle_tone | 1.13797273 |
| 53 | MP0003633_abnormal_nervous_system | 1.13349140 |
| 54 | MP0004742_abnormal_vestibular_system | 1.07464818 |
| 55 | MP0003123_paternal_imprinting | 1.06817278 |
| 56 | MP0003122_maternal_imprinting | 1.06707742 |
| 57 | MP0005409_darkened_coat_color | 1.05424506 |
| 58 | MP0005499_abnormal_olfactory_system | 0.99360408 |
| 59 | MP0005394_taste/olfaction_phenotype | 0.99360408 |
| 60 | MP0003631_nervous_system_phenotype | 0.99155413 |
| 61 | MP0002069_abnormal_eating/drinking_beha | 0.97305166 |
| 62 | MP0000631_abnormal_neuroendocrine_gland | 0.95697224 |
| 63 | MP0000751_myopathy | 0.94806720 |
| 64 | MP0003690_abnormal_glial_cell | 0.94774109 |
| 65 | MP0010386_abnormal_urinary_bladder | 0.93590305 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 0.89619989 |
| 67 | MP0008872_abnormal_physiological_respon | 0.87094081 |
| 68 | MP0001177_atelectasis | 0.86174167 |
| 69 | MP0004085_abnormal_heartbeat | 0.85754135 |
| 70 | MP0002752_abnormal_somatic_nervous | 0.84705432 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 0.84238359 |
| 72 | MP0002229_neurodegeneration | 0.83520287 |
| 73 | MP0008874_decreased_physiological_sensi | 0.83336833 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 0.83175952 |
| 75 | MP0001963_abnormal_hearing_physiology | 0.82394496 |
| 76 | MP0000604_amyloidosis | 0.81632467 |
| 77 | * MP0003861_abnormal_nervous_system | 0.79253100 |
| 78 | MP0005535_abnormal_body_temperature | 0.79092772 |
| 79 | MP0003634_abnormal_glial_cell | 0.77532243 |
| 80 | MP0004133_heterotaxia | 0.76365445 |
| 81 | MP0006292_abnormal_olfactory_placode | 0.74528555 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.73247118 |
| 83 | MP0003137_abnormal_impulse_conducting | 0.72883758 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.72359836 |
| 85 | MP0005187_abnormal_penis_morphology | 0.69491752 |
| 86 | MP0002102_abnormal_ear_morphology | 0.69213092 |
| 87 | MP0003632_abnormal_nervous_system | 0.68806952 |
| 88 | MP0004510_myositis | 0.68472197 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.66803639 |
| 90 | MP0003938_abnormal_ear_development | 0.65316796 |
| 91 | MP0005623_abnormal_meninges_morphology | 0.65068450 |
| 92 | MP0010768_mortality/aging | 0.64813395 |
| 93 | MP0004484_altered_response_of | 0.63778416 |
| 94 | MP0001664_abnormal_digestion | 0.63700801 |
| 95 | MP0001485_abnormal_pinna_reflex | 0.62943293 |
| 96 | MP0000920_abnormal_myelination | 0.61767046 |
| 97 | MP0003283_abnormal_digestive_organ | 0.61064709 |
| 98 | MP0000026_abnormal_inner_ear | 0.60747320 |
| 99 | MP0001943_abnormal_respiration | 0.60691423 |
| 100 | MP0000566_synostosis | 0.60579569 |
| 101 | * MP0002081_perinatal_lethality | 0.60052112 |
| 102 | MP0002090_abnormal_vision | 0.59966586 |
| 103 | MP0002751_abnormal_autonomic_nervous | 0.59528994 |
| 104 | MP0003075_altered_response_to | 0.58632027 |
| 105 | MP0002234_abnormal_pharynx_morphology | 0.58448091 |
| 106 | MP0009379_abnormal_foot_pigmentation | 0.58285665 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.57651170 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.57132803 |
| 109 | MP0002653_abnormal_ependyma_morphology | 0.56520340 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.55982935 |
| 111 | MP0010769_abnormal_survival | 0.55874954 |
| 112 | MP0010770_preweaning_lethality | 0.55702051 |
| 113 | MP0002082_postnatal_lethality | 0.55702051 |
| 114 | MP0003956_abnormal_body_size | 0.50794274 |
| 115 | MP0003890_abnormal_embryonic-extraembry | 0.48822427 |
| 116 | MP0001299_abnormal_eye_distance/ | 0.48806284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.42031309 |
| 2 | Myokymia (HP:0002411) | 6.31226730 |
| 3 | Focal seizures (HP:0007359) | 5.67427340 |
| 4 | Visual hallucinations (HP:0002367) | 5.22935807 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.80421559 |
| 6 | Atonic seizures (HP:0010819) | 4.37881794 |
| 7 | Febrile seizures (HP:0002373) | 4.18364685 |
| 8 | Absence seizures (HP:0002121) | 4.06472106 |
| 9 | Broad-based gait (HP:0002136) | 4.00171838 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.99260389 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.94878220 |
| 12 | Dialeptic seizures (HP:0011146) | 3.72090497 |
| 13 | Hyperventilation (HP:0002883) | 3.70733748 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.70288015 |
| 15 | Poor eye contact (HP:0000817) | 3.53440380 |
| 16 | Mutism (HP:0002300) | 3.45130055 |
| 17 | Amblyopia (HP:0000646) | 3.43706013 |
| 18 | Excessive salivation (HP:0003781) | 3.38812257 |
| 19 | Drooling (HP:0002307) | 3.38812257 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 3.21630098 |
| 21 | Ankle clonus (HP:0011448) | 3.17679480 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.17631631 |
| 23 | Action tremor (HP:0002345) | 3.15918485 |
| 24 | Abnormal social behavior (HP:0012433) | 3.12018421 |
| 25 | Impaired social interactions (HP:0000735) | 3.12018421 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.07034045 |
| 27 | Papilledema (HP:0001085) | 3.05066449 |
| 28 | Limb dystonia (HP:0002451) | 3.01650688 |
| 29 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.00664822 |
| 30 | Amyotrophic lateral sclerosis (HP:0007354) | 3.00363097 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 2.93510174 |
| 32 | Depression (HP:0000716) | 2.91746894 |
| 33 | Hemiparesis (HP:0001269) | 2.90785144 |
| 34 | Truncal ataxia (HP:0002078) | 2.89620570 |
| 35 | Anxiety (HP:0000739) | 2.83865468 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.83114041 |
| 37 | Progressive inability to walk (HP:0002505) | 2.82436728 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.79887972 |
| 39 | Peripheral hypomyelination (HP:0007182) | 2.79647427 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 2.77916779 |
| 41 | Urinary urgency (HP:0000012) | 2.76683845 |
| 42 | Stereotypic behavior (HP:0000733) | 2.74580708 |
| 43 | Termporal pattern (HP:0011008) | 2.73654196 |
| 44 | Insidious onset (HP:0003587) | 2.73654196 |
| 45 | Dysmetria (HP:0001310) | 2.69065314 |
| 46 | Epileptiform EEG discharges (HP:0011182) | 2.64837175 |
| 47 | Genetic anticipation (HP:0003743) | 2.63234351 |
| 48 | Abnormality of binocular vision (HP:0011514) | 2.62799159 |
| 49 | Diplopia (HP:0000651) | 2.62799159 |
| 50 | Absent speech (HP:0001344) | 2.62200292 |
| 51 | Polyphagia (HP:0002591) | 2.61750498 |
| 52 | Abnormality of the lower motor neuron (HP:0002366) | 2.57611561 |
| 53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.55973021 |
| 54 | Fetal akinesia sequence (HP:0001989) | 2.55261780 |
| 55 | Spastic gait (HP:0002064) | 2.52467396 |
| 56 | Inappropriate behavior (HP:0000719) | 2.49881262 |
| 57 | Inability to walk (HP:0002540) | 2.46855562 |
| 58 | Megalencephaly (HP:0001355) | 2.44545867 |
| 59 | Hypsarrhythmia (HP:0002521) | 2.42316868 |
| 60 | Torticollis (HP:0000473) | 2.41613398 |
| 61 | Impaired smooth pursuit (HP:0007772) | 2.38049609 |
| 62 | Cerebral hypomyelination (HP:0006808) | 2.32852960 |
| 63 | Postural instability (HP:0002172) | 2.32397356 |
| 64 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.31831089 |
| 65 | Protruding tongue (HP:0010808) | 2.30970894 |
| 66 | Focal dystonia (HP:0004373) | 2.30212907 |
| 67 | Agitation (HP:0000713) | 2.28450071 |
| 68 | Abnormality of salivation (HP:0100755) | 2.27759329 |
| 69 | Obstructive sleep apnea (HP:0002870) | 2.24352706 |
| 70 | Bradykinesia (HP:0002067) | 2.23091265 |
| 71 | Apathy (HP:0000741) | 2.19553139 |
| 72 | Lower limb muscle weakness (HP:0007340) | 2.16350783 |
| 73 | Akinesia (HP:0002304) | 2.14795665 |
| 74 | Generalized myoclonic seizures (HP:0002123) | 2.11673490 |
| 75 | Spastic tetraplegia (HP:0002510) | 2.09860566 |
| 76 | Hypoplasia of the corpus callosum (HP:0002079) | 2.09758100 |
| 77 | Scanning speech (HP:0002168) | 2.07562615 |
| 78 | Clonus (HP:0002169) | 2.05334425 |
| 79 | Hypoplasia of the brainstem (HP:0002365) | 2.04275483 |
| 80 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.04275483 |
| 81 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.02556112 |
| 82 | Status epilepticus (HP:0002133) | 2.02511330 |
| 83 | Intention tremor (HP:0002080) | 2.01647680 |
| 84 | Craniofacial dystonia (HP:0012179) | 2.00602043 |
| 85 | Lower limb asymmetry (HP:0100559) | 2.00153800 |
| 86 | Intellectual disability, severe (HP:0010864) | 1.99929998 |
| 87 | Impaired vibratory sensation (HP:0002495) | 1.97310840 |
| 88 | Ulnar claw (HP:0001178) | 1.96994047 |
| 89 | Lower limb amyotrophy (HP:0007210) | 1.94938603 |
| 90 | Lissencephaly (HP:0001339) | 1.94287960 |
| 91 | Split foot (HP:0001839) | 1.94219955 |
| 92 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.94091989 |
| 93 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.94091989 |
| 94 | Esotropia (HP:0000565) | 1.93929570 |
| 95 | Abnormality of the labia minora (HP:0012880) | 1.93467238 |
| 96 | Exotropia (HP:0000577) | 1.92361874 |
| 97 | Diminished motivation (HP:0000745) | 1.92053335 |
| 98 | Hyperthyroidism (HP:0000836) | 1.91953072 |
| 99 | Pointed chin (HP:0000307) | 1.91145701 |
| 100 | Blue irides (HP:0000635) | 1.89010172 |
| 101 | Insomnia (HP:0100785) | 1.88639105 |
| 102 | Sporadic (HP:0003745) | 1.88321518 |
| 103 | Failure to thrive in infancy (HP:0001531) | 1.87845121 |
| 104 | Neuronal loss in central nervous system (HP:0002529) | 1.86810317 |
| 105 | Sleep apnea (HP:0010535) | 1.84932068 |
| 106 | Gait imbalance (HP:0002141) | 1.84787115 |
| 107 | Hemiplegia (HP:0002301) | 1.84654949 |
| 108 | Specific learning disability (HP:0001328) | 1.84380544 |
| 109 | Autism (HP:0000717) | 1.84164830 |
| 110 | Delusions (HP:0000746) | 1.83264134 |
| 111 | Annular pancreas (HP:0001734) | 1.83170508 |
| 112 | Incomplete penetrance (HP:0003829) | 1.80936071 |
| 113 | Pachygyria (HP:0001302) | 1.78802322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.77154306 |
| 2 | EPHA4 | 4.74297159 |
| 3 | NTRK3 | 4.04126095 |
| 4 | MAP3K9 | 3.78812181 |
| 5 | MAP3K4 | 3.04415762 |
| 6 | MINK1 | 2.67646999 |
| 7 | MAP2K7 | 2.62841224 |
| 8 | DAPK2 | 2.53310609 |
| 9 | NTRK2 | 2.33315628 |
| 10 | RIPK4 | 2.26928589 |
| 11 | CASK | 2.14082879 |
| 12 | PAK6 | 2.12814230 |
| 13 | PNCK | 2.02846710 |
| 14 | KSR1 | 1.96379049 |
| 15 | MAP3K12 | 1.92208260 |
| 16 | KSR2 | 1.88161804 |
| 17 | MAP2K4 | 1.81962142 |
| 18 | MAPK13 | 1.79542495 |
| 19 | NTRK1 | 1.62792586 |
| 20 | PLK2 | 1.58442002 |
| 21 | TNIK | 1.55707736 |
| 22 | DAPK1 | 1.53988191 |
| 23 | * CDK5 | 1.53296628 |
| 24 | CAMKK1 | 1.47060388 |
| 25 | PINK1 | 1.44228757 |
| 26 | PRKD3 | 1.41261312 |
| 27 | GRK5 | 1.34110104 |
| 28 | UHMK1 | 1.23909664 |
| 29 | FES | 1.20979787 |
| 30 | PRKCG | 1.18121297 |
| 31 | TYRO3 | 1.14244070 |
| 32 | PHKG2 | 1.12104470 |
| 33 | PHKG1 | 1.12104470 |
| 34 | LATS2 | 1.07407013 |
| 35 | PRPF4B | 1.05490002 |
| 36 | CDK19 | 1.02979967 |
| 37 | CAMK2A | 1.00865592 |
| 38 | ARAF | 0.98838222 |
| 39 | MAP3K2 | 0.93943594 |
| 40 | CDK18 | 0.93833406 |
| 41 | DYRK1A | 0.93676140 |
| 42 | CSNK1G2 | 0.92236538 |
| 43 | CDK15 | 0.91760396 |
| 44 | BMPR2 | 0.91186692 |
| 45 | CDK14 | 0.91097896 |
| 46 | STK11 | 0.90162560 |
| 47 | TAOK2 | 0.89975261 |
| 48 | DYRK2 | 0.84744820 |
| 49 | FGR | 0.83759069 |
| 50 | MAP3K13 | 0.82781343 |
| 51 | RAF1 | 0.81976859 |
| 52 | CDK11A | 0.81132883 |
| 53 | CAMK2B | 0.79184473 |
| 54 | TAOK1 | 0.78280816 |
| 55 | RET | 0.78159464 |
| 56 | MARK2 | 0.78053080 |
| 57 | PTK2B | 0.75707099 |
| 58 | PAK3 | 0.75563971 |
| 59 | STK38 | 0.75260927 |
| 60 | CAMK1 | 0.70318348 |
| 61 | MAP3K6 | 0.70235570 |
| 62 | SGK223 | 0.69936773 |
| 63 | SGK494 | 0.69936773 |
| 64 | NME1 | 0.69342517 |
| 65 | SGK1 | 0.67996302 |
| 66 | CAMKK2 | 0.67149522 |
| 67 | ERBB3 | 0.65397567 |
| 68 | MAP2K6 | 0.64156141 |
| 69 | CCNB1 | 0.56078969 |
| 70 | PKN1 | 0.55802281 |
| 71 | CAMK1G | 0.54822942 |
| 72 | MAP4K2 | 0.54632891 |
| 73 | TRIM28 | 0.53338353 |
| 74 | OXSR1 | 0.53144364 |
| 75 | PRKCE | 0.52354917 |
| 76 | * PRKCZ | 0.51822099 |
| 77 | SGK2 | 0.51277301 |
| 78 | WNK3 | 0.51125106 |
| 79 | PRKCH | 0.49722134 |
| 80 | FYN | 0.49575699 |
| 81 | MAPK12 | 0.48609499 |
| 82 | FGFR2 | 0.48292597 |
| 83 | BCR | 0.46743926 |
| 84 | ALK | 0.44811090 |
| 85 | CAMK2G | 0.43945100 |
| 86 | RPS6KA3 | 0.42825586 |
| 87 | CSNK1G3 | 0.42476629 |
| 88 | RIPK1 | 0.42375787 |
| 89 | MAP3K5 | 0.42173836 |
| 90 | PDPK1 | 0.39793067 |
| 91 | MAPK10 | 0.39667906 |
| 92 | PDK1 | 0.39413838 |
| 93 | MAP2K1 | 0.39138980 |
| 94 | DYRK1B | 0.38647533 |
| 95 | DAPK3 | 0.37928569 |
| 96 | EPHA3 | 0.36578636 |
| 97 | CSNK1G1 | 0.36362600 |
| 98 | ROCK2 | 0.36062414 |
| 99 | RPS6KA2 | 0.36017375 |
| 100 | CSNK1D | 0.35763573 |
| 101 | SGK3 | 0.35437558 |
| 102 | GRK7 | 0.34418820 |
| 103 | IRAK2 | 0.34369466 |
| 104 | CAMK2D | 0.34214766 |
| 105 | MAPK8 | 0.33968384 |
| 106 | CAMK1D | 0.32177420 |
| 107 | NEK6 | 0.32126938 |
| 108 | PRKCB | 0.31958540 |
| 109 | MAPK4 | 0.31502539 |
| 110 | CAMK4 | 0.31471446 |
| 111 | DMPK | 0.31406499 |
| 112 | PRKACA | 0.30776062 |
| 113 | CSNK1A1L | 0.30735182 |
| 114 | EPHB2 | 0.29947696 |
| 115 | MAP3K1 | 0.29533566 |
| 116 | CDC42BPA | 0.28899955 |
| 117 | GSK3B | 0.28509858 |
| 118 | PRKG1 | 0.27937702 |
| 119 | SIK3 | 0.27822392 |
| 120 | CSNK1E | 0.27231475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.89844745 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.97221665 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75953266 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.74922175 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.67692379 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66968774 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66489397 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.59677160 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.52348154 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.48413310 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.29767712 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.11707830 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.08774602 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96551566 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.85372269 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.82989824 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.82619169 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82053330 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.80981635 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.79225402 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75440537 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.73404956 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65889014 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56617751 |
| 25 | Axon guidance_Homo sapiens_hsa04360 | 1.56544525 |
| 26 | * Cocaine addiction_Homo sapiens_hsa05030 | 1.56523386 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.52599735 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49427148 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39183891 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34410597 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27125673 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22947464 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22938564 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.20863902 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.18720141 |
| 36 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13749881 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13731698 |
| 38 | Melanogenesis_Homo sapiens_hsa04916 | 1.11224561 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11122602 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08512884 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05091182 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01398284 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01078292 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 0.98221291 |
| 45 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92238031 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87645383 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83265738 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80726211 |
| 49 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80539475 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80417726 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79777692 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78559736 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78210789 |
| 54 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77193892 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73998246 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73244911 |
| 57 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72089832 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70739250 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68771029 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68310461 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67448792 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66700747 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64582464 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63873642 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63256817 |
| 66 | Alcoholism_Homo sapiens_hsa05034 | 0.63126078 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62718925 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62379947 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60303482 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58975986 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58840490 |
| 72 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.56578483 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56321771 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55921231 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54677147 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53595258 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53328731 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51758473 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50570366 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50036890 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49272375 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49233558 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47703937 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.45918496 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.45731787 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45654559 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45311199 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44268584 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.43541567 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41776381 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39530682 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38588429 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38076790 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37831969 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37315578 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37275885 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37046911 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34408073 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34374471 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.34147916 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33738348 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32797662 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32148241 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32035333 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31698390 |
| 106 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31321813 |
| 107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29567454 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29398763 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28262078 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27968340 |
| 111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23825468 |

